[1] Peirce V, Carobbio S, Vidal-Puig A.The different shades of fat[J]. Nature,2014,510(7503):76-83. [2] Cannon B, Nedergaard J.Brown adipose tissue: function and physiological significance[J]. Physiol Rev, 2004,84(1):277-359. [3] Villarroya F, Cereijo R, Villarroya J, et al.Brown adipose tissue as a secretory organ[J]. Nat Rev Endocrinol,2017, 13(1):26-35. [4] Stanford KI, Middelbeek RJ, Townsend KL, et al.Brown adipose tissue regulates glucose homeostasis and insulin sensitivity[J]. J Clin Invest,2013,123(1):215-223. [5] Zingaretti M1, Crosta F, Vitali A, et al. The presence of UCP1 demonstrates that metabolically active adipose tissue in the neck of adult humans truly represents brown adipose tissue[J]. FASEB J, 2009, 23(9):3113-3120. [6] Fernandes-Santos C, Carneiro RE, de Souza Mendonca L, et al. Pan-PPAR agonist beneficial effects in overweight mice fed a high-fat high-sucrose diet[J]. Nutrition,2009, 25(7-8):818-827. [7] Harms M, Seale P.Brown and beige fat: development, function and therapeutic potential[J]. Nat Med,2013,19(10):1252-1263. [8] Price NL, Fernándezhernando C .miRNA regulation of white and brown adipose tissue differentiation and function[J]. Biochim Biophys Acta, 2016,1861(12PtB):2104-2110. [9] Kim SY, Kim AY, Lee HW,et al.miR-27a is a negative regulator of adipocyte differentiation via suppressing PPARgamma expression[J]. Biochem Biophys Res Commun,2010,392(3):323-328. [10] Karbiener M, Fischer C, Nowitsch S, et al.microRNA miR-27b impairs human adipocyte differentiation and targets PPARgamma[J]. Biochem Biophys Res Commun,2009,390(2):247-251. [11] Lin Q, Gao Z, Alarcon RM, et al.A role of miR-27 in the regulation of adipogenesis[J]. FEBS J,2009,276(8):2348-2358. [12] Lee EK, Lee MJ, Abdelmohsen K, et al.miR-130 suppresses adipogenesis by inhibiting peroxisome proliferator-activated receptor gamma expression[J]. Mol Cell Biol,2011,31(4):626-638. [13] Kim YJ, Hwang SJ, Bae YC, et al.MiR-21 regulates adipogenic differentiation through the modulation of TGF-beta signaling in mesenchymal stem cells derived from human adipose tissue[J]. Stem Cells, 2009,27(12):3093-3102. [14] Yi C, Xie WD, Li F, et al.MiR-143 enhances adipogenic differentiation of 3T3-L1 cells through targeting the co-ding region of mouse pleiotrophin[J]. FEBS Lett,2011, 585(20):3303-3309. [15] Villarreal-Molina MT, Antuna-Puente B.Adiponectin: anti-inflammatory and cardioprotective effects[J]. Biochimie,2012,94(10):2143-2149. [16] Guerre-Millo M.Adiponectin: an update[J]. Diabetes Metab,2008,34(1):12-18. [17] Awazawa M, Ueki K, Inabe K, et al.Adiponectin enhances insulin sensitivity by increasing hepatic IRS-2 expression via a macrophage-derived IL-6-dependent pathway[J]. Cell Metab,2011,13(4):401-412. [18] Kadowaki T, Yamauchi T, Kubota N, et al.Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome[J]. J Clin Invest,2006,116(7):1784-1792. [19] Frühbeck G, Catalán V, Rodríguez A, et al.Adiponectin-leptin ratio: A promising index to estimate adipose tissue dysfunction. Relation with obesity-associated cardiometabolic risk[J]. Adipocyte,2017:1-6. [20] Bhaumik D, Scott GK, Schokrpur S, et al.Expression of microRNA-146 suppresses NF-kappaB activity with reduction of metastatic potential in breast cancer cells[J]. Oncogene,2008,27(42):5643-5647. [21] Hulsmans M, van Dooren E, Mathieu C, et al. Decrease of miR-146b-5p in monocytes during obesity is associa-ted with loss of the anti-inflammatory but not insulin signaling action of adiponectin[J]. PLoS One,2012,7(2):e32794. |